SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-000707
Filing Date
2024-02-14
Accepted
2024-02-14 16:46:42
Documents
1
Group Members
DAVID EINHORNDME ADVISORS GP, LLCDME ADVISORS, LPDME CAPITAL MANAGEMENT, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 sch13ga.htm SC 13G/A 83366
  Complete submission text file 0000929638-24-000707.txt   85336
Mailing Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017
Business Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017 2129731900
GREENLIGHT CAPITAL INC (Filed by) CIK: 0001079114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82720 | Film No.: 24639666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)